Advertisement

Topics

Experts Comment on FDA's DSCSA Serialization Extension: Manufacturers Now Have Until 2018

10:50 EDT 9 Aug 2017 | PharmPro

As of June 30, 2017, the U.S. FDA extended the Product Identifier Requirements under the Drug Supply Chain Security Act (DSCSA). Companies will no longer be penalized if they don't meet the November 27, 2017 serialization deadline. So, what does that mean for pharmaceutical manufacturers going forward?
Staff Author: 
Topics: 

Original Article: Experts Comment on FDA's DSCSA Serialization Extension: Manufacturers Now Have Until 2018

NEXT ARTICLE

More From BioPortfolio on "Experts Comment on FDA's DSCSA Serialization Extension: Manufacturers Now Have Until 2018"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...